CIN2 Clinical Trial
Official title:
Performance of Tampons as a Biospecimen Collection Tool for the Detection of Human Papillomavirus in a Colposcopy Setting
Evaluation of the clinical performance of the Daye Diagnostic Tampon (DDT) for the detection of Human Papilloma Virus (HPV) infection associated with high grade cervical disease. Cross sectional design with comparison to a clinician taken biospecimen. Performance will be measured relative to the presence/absence of histologically confirmed disease
Type of Study: Clinical Trial Goal: The goal of this clinical trial is to evaluate the clinical performance of the Daye Diagnostic Tampon (DDT) for the detection of HPV infection associated with high-grade cervical disease. Main Questions: What is the sensitivity and specificity of molecular HPV assays in detecting high-grade cervical disease (CIN2+) using the DDT compared to a clinician-taken, liquid-based cytology (LBC) sample? How does the relative sensitivity and specificity of HPV detection in the tampon compare to the LBC sample for the detection of CIN2+? Participants: Women attending routine colposcopy clinics as part of standard care. Main Tasks: Provide informed consent. Undergo routine colposcopy. Use the DAYE Diagnostic Tampon (DDT). Provide a clinician-taken liquid-based cytology (LBC) sample. Complete a short questionnaire. Comparison Group: Researchers will compare the performance of the DAYE Diagnostic Tampon (DDT) to a clinician-taken, liquid-based cytology (LBC) sample to determine if there are differences in sensitivity and specificity for the detection of high-grade cervical disease (CIN2+). The comparison will assess the relative sensitivity and specificity of HPV detection in the tampon versus the LBC sample for the presence/absence of histologically confirmed disease. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05372016 -
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
| Recruiting |
NCT05027776 -
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
|
Phase 3 | |
| Recruiting |
NCT06147388 -
Regression of Cervical Precancerous Lesions and Associated Risk Factors
|
||
| Completed |
NCT03676101 -
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 1 | |
| Recruiting |
NCT04895020 -
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
|
Phase 3 | |
| Completed |
NCT04425291 -
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
| Active, not recruiting |
NCT01881659 -
Cervical Cancer Screening With Human Papillomavirus Testing
|
||
| Recruiting |
NCT05371353 -
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
|
||
| Recruiting |
NCT05413798 -
Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
|
N/A | |
| Recruiting |
NCT05413811 -
Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
|
N/A | |
| Completed |
NCT03177863 -
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age
|
N/A | |
| Terminated |
NCT05584332 -
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
| Recruiting |
NCT02956031 -
Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
|
||
| Recruiting |
NCT04422366 -
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
| Completed |
NCT02405533 -
Phase II Evaluation of AHCC for the Eradication of HPV Infections
|
N/A | |
| Completed |
NCT04687267 -
Conservative Management of CIN2 Lesions and Biomarkers Evaluation
|